AS
KURA icon

Altshuler Shaham’s Kura Oncology KURA Stock Holding History

Altshuler Shaham’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-13,900
Closed -$255K – 504
2022
Q2 		$255K Hold
13,900
– – ﹤0.01% 123
2022
Q1 		$224K Sell
13,900
-10,200
-42% -$147K ﹤0.01% 206
2021
Q4 		$337K Hold
24,100
– – ﹤0.01% 213
2021
Q3 		$454K Hold
24,100
– – ﹤0.01% 203
2021
Q2 		$502K Hold
24,100
– – ﹤0.01% 203
2021
Q1 		$681K Hold
24,100
– – 0.01% 113
2020
Q4 		$787K Sell
24,100
-5,300
-18% -$186K 0.02% 81
2020
Q3 		$901K Hold
29,400
– – 0.02% 78
2020
Q2 		$479K Buy
+29,400
New +$424K 0.01% 105

Other funds holding KURA

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Altshuler Shaham's KURA Position: Q3 2022 in Review

Altshuler Shaham sold out of Kura Oncology (KURA) in Q3 2022, closing a stake of 13,900 shares — an estimated $255K sold.

Altshuler Shaham first reported a position in KURA in Q2 2020 and held it in 9 quarters. The position peaked at $901K in Q3 2020. 148 funds tracked by Wall St. Rank hold KURA as of Q3 2022.

  • Altshuler Shaham reported no remaining Kura Oncology position as of Q3 2022 after selling out during the quarter.
  • Altshuler Shaham sold 13,900 Kura Oncology shares in Q3 2022, an estimated $255K.
  • Altshuler Shaham first reported a position in Kura Oncology in Q2 2020 and held it in 9 quarters.
  • Altshuler Shaham's Kura Oncology position peaked at $901K in Q3 2020.
  • 148 funds tracked by Wall St. Rank held Kura Oncology as of Q3 2022.

Based on Altshuler Shaham's 13F filing for Q3 2022, filed 14 Nov 2022.